Literature DB >> 17217625

Notch signaling enhances nestin expression in gliomas.

Alan H Shih1, Eric C Holland.   

Abstract

Recent findings suggest that Notch signaling is active in brain tumors and stem cells, and that stem cells or cells with progenitor characteristics contribute to brain tumor formation. These stem cells are marked by expression of several markers, including nestin, an intermediate filament protein. We have studied how the Notch signaling pathway affects nestin expression in brain tumors. We find that Notch receptors and ligands are expressed in vitro and in human samples of glioblastomas, the highest grade of malignant gliomas. In culture, Notch activity activates the nestin promoter. Activation of the Notch pathway also occurs in a glioblastoma multiforme mouse model induced by Kras, with translational regulation playing a role in Notch expression. Combined activation of Notch and Kras in wild-type nestin-expressing cells leads to their expansion within the subventricular zone and retention of proliferation and nestin expression. However, activation of Notch alone is unable to induce this cellular expansion. These data suggest that Notch may have a contributing role in the stem-like character of glioma cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17217625      PMCID: PMC1790729          DOI: 10.1593/neo.06526

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  42 in total

1.  Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells.

Authors:  S J Morrison; S E Perez; Z Qiao; J M Verdi; C Hicks; G Weinmaster; D J Anderson
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

2.  Radial glial identity is promoted by Notch1 signaling in the murine forebrain.

Authors:  N Gaiano; J S Nye; G Fishell
Journal:  Neuron       Date:  2000-05       Impact factor: 17.173

3.  Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.

Authors:  E C Holland; J Celestino; C Dai; L Schaefer; R E Sawaya; G N Fuller
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

4.  PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

Authors:  C Dai; J C Celestino; Y Okada; D N Louis; G N Fuller; E C Holland
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

5.  Ras pathway signals are required for notch-mediated oncogenesis.

Authors:  K Fitzgerald; A Harrington; P Leder
Journal:  Oncogene       Date:  2000-08-31       Impact factor: 9.867

6.  Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic).

Authors:  C Ronchini; A J Capobianco
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

7.  Notch1 and Notch3 instructively restrict bFGF-responsive multipotent neural progenitor cells to an astroglial fate.

Authors:  K Tanigaki; F Nogaki; J Takahashi; K Tashiro; H Kurooka; T Honjo
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

8.  MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo.

Authors:  Dan Fults; Carolyn Pedone; Chengkai Dai; Eric C Holland
Journal:  Neoplasia       Date:  2002 Jan-Feb       Impact factor: 5.715

9.  Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells.

Authors:  Seiji Hitoshi; Tania Alexson; Vincent Tropepe; Dorit Donoviel; Andrew J Elia; Jeffrey S Nye; Ronald A Conlon; Tak W Mak; Alan Bernstein; Derek van der Kooy
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

10.  Nestin enhancer requirements for expression in normal and injured adult CNS.

Authors:  Clas B Johansson; Carina Lothian; Magnus Molin; Hideyuki Okano; Urban Lendahl
Journal:  J Neurosci Res       Date:  2002-09-15       Impact factor: 4.164

View more
  86 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

2.  Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.

Authors:  Candace A Gilbert; Marie-Claire Daou; Richard P Moser; Alonzo H Ross
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

3.  Adult epidermal Notch activity induces dermal accumulation of T cells and neural crest derivatives through upregulation of jagged 1.

Authors:  Carrie A Ambler; Fiona M Watt
Journal:  Development       Date:  2010-11       Impact factor: 6.868

4.  Notch/Rbpjκ signaling regulates progenitor maintenance and differentiation of hypothalamic arcuate neurons.

Authors:  Paven K Aujla; George T Naratadam; Liwen Xu; Lori T Raetzman
Journal:  Development       Date:  2013-07-24       Impact factor: 6.868

Review 5.  Cancer stem cells: a new framework for the design of tumor therapies.

Authors:  Boyan K Garvalov; Till Acker
Journal:  J Mol Med (Berl)       Date:  2010-10-02       Impact factor: 4.599

6.  Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.

Authors:  Lan Dai; Jintang He; Yashu Liu; Jaeman Byun; Anuradha Vivekanandan; Subramaniam Pennathur; Xing Fan; David M Lubman
Journal:  Proteomics       Date:  2011-10-24       Impact factor: 3.984

7.  Low Concentration Microenvironments Enhance the Migration of Neonatal Cells of Glial Lineage.

Authors:  Richard A Able; Celestin Ngnabeuye; Cade Beck; Eric C Holland; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2012-06       Impact factor: 2.321

8.  MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.

Authors:  Yunqing Li; Fadila Guessous; Ying Zhang; Charles Dipierro; Benjamin Kefas; Elizabeth Johnson; Lukasz Marcinkiewicz; Jinmai Jiang; Yanzhi Yang; Thomas D Schmittgen; Beatriz Lopes; David Schiff; Benjamin Purow; Roger Abounader
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

Review 9.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

10.  NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.

Authors:  Xing Fan; Leila Khaki; Thant S Zhu; Mary E Soules; Caroline E Talsma; Naheed Gul; Cheryl Koh; Jiangyang Zhang; Yue-Ming Li; Jarek Maciaczyk; Guido Nikkhah; Francesco Dimeco; Sara Piccirillo; Angelo L Vescovi; Charles G Eberhart
Journal:  Stem Cells       Date:  2010-01       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.